COMMISSION REGULATION (EU) 2024/2633 of 8 October 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, famoxadone, flutriafol, mandipropamid and mefentrifluconazole in or on certain products (Text with EEA relevance)